Comments
Loading...

Teladoc Health Analyst Ratings

TDOCNYSE
Logo brought to you by Benzinga Data
$7.14
At close: Apr 16 EDT
$7.19
0.050.70%
Pre-Market: 6:14 AM EDT
Consensus Rating1
Hold
Highest Price Target1
$40.00
Lowest Price Target1
$8.00
Consensus Price Target1
$18.60

Teladoc Health Analyst Ratings and Price Targets | NYSE:TDOC | Benzinga

Teladoc Health Inc has a consensus price target of $18.6 based on the ratings of 33 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $8 issued by B of A Securities on April 11, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Goldman Sachs, and Piper Sandler on April 11, 2025, March 3, 2025, and February 27, 2025, respectively. With an average price target of $11 between B of A Securities, Goldman Sachs, and Piper Sandler, there's an implied 52.99% upside for Teladoc Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
2
2
Feb
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Goldman Sachs
Piper Sandler
RBC Capital
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Teladoc Health

Buy NowGet Alert
04/11/2025Buy Now11.27%B of A Securities
Allen Lutz62%
$9.5 → $8MaintainsNeutralGet Alert
03/03/2025Buy Now80.81%Goldman Sachs
David Roman35%
$16 → $13MaintainsBuyGet Alert
02/27/2025Buy NowNeedham
Ryan MacDonald57%
ReiteratesHold → HoldGet Alert
02/27/2025Buy Now66.9%Piper Sandler
Jessica Tassan41%
$13 → $12MaintainsOverweightGet Alert
02/18/2025Buy Now122.53%Goldman Sachs
David Roman35%
$14 → $16MaintainsBuyGet Alert
02/12/2025Buy Now87.76%B of A Securities
Allen Lutz62%
$11.5 → $13.5MaintainsNeutralGet Alert
02/06/2025Buy Now59.94%B of A Securities
Allen Lutz62%
$10.5 → $11.5MaintainsNeutralGet Alert
01/24/2025Buy Now66.9%RBC Capital
Sean Dodge48%
$11 → $12MaintainsOutperformGet Alert
01/24/2025Buy Now66.9%Oppenheimer
Michael Wiederhorn63%
$14 → $12MaintainsOutperformGet Alert
12/04/2024Buy Now80.81%Piper Sandler
Jessica Tassan41%
$11 → $13ReiteratesOverweight → OverweightGet Alert
11/15/2024Buy Now94.71%Goldman Sachs
David Roman35%
→ $14Initiates → BuyGet Alert
11/01/2024Buy Now66.9%Deutsche Bank
George Hill64%
$10 → $12MaintainsHoldGet Alert
10/31/2024Buy Now66.9%Barclays
Steve Valiquette55%
$10 → $12MaintainsOverweightGet Alert
10/31/2024Buy Now11.27%TD Cowen
Charles Rhyee37%
$9 → $8MaintainsHoldGet Alert
10/09/2024Buy Now39.08%RBC Capital
Sean Dodge48%
$9 → $10MaintainsOutperformGet Alert
10/08/2024Buy Now25.17%Evercore ISI Group
Elizabeth Anderson45%
$8 → $9MaintainsIn-LineGet Alert
09/17/2024Buy Now39.08%Jefferies
Glen Santangelo50%
$8 → $10MaintainsHoldGet Alert
08/26/2024Buy Now25.17%JP Morgan
Lisa Gill60%
$16 → $9MaintainsNeutralGet Alert
08/20/2024Buy Now39.08%Cantor Fitzgerald
Sarah James53%
$10 → $10ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy Now39.08%Piper Sandler
Jessica Tassan41%
$25 → $10MaintainsOverweightGet Alert
08/02/2024Buy Now39.08%Deutsche Bank
George Hill64%
$15 → $10MaintainsHoldGet Alert
08/02/2024Buy Now39.08%Truist Securities
Jailendra Singh38%
$15 → $10MaintainsHoldGet Alert
08/01/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
08/01/2024Buy Now25.17%TD Cowen
Charles Rhyee37%
$15 → $9MaintainsHoldGet Alert
08/01/2024Buy Now25.17%RBC Capital
Sean Dodge48%
$18 → $9MaintainsOutperformGet Alert
08/01/2024Buy Now39.08%Barclays
Steve Valiquette55%
$20 → $10MaintainsOverweightGet Alert
08/01/2024Buy Now25.17%Stifel
David Grossman62%
$16 → $9MaintainsHoldGet Alert
08/01/2024Buy Now11.27%DA Davidson
Gil Luria49%
$12 → $8MaintainsNeutralGet Alert
08/01/2024Buy Now136.44%Canaccord Genuity
Richard Close46%
$25 → $17MaintainsBuyGet Alert
08/01/2024Buy Now136.44%Oppenheimer
Michael Wiederhorn63%
$21 → $17MaintainsOutperformGet Alert
07/09/2024Buy Now39.08%Evercore ISI Group
Elizabeth Anderson45%
$14 → $10MaintainsIn-LineGet Alert
05/21/2024Buy Now122.53%JP Morgan
Lisa Gill60%
$19 → $16MaintainsNeutralGet Alert
05/20/2024Buy Now94.71%Jefferies
Glen Santangelo50%
$16 → $14MaintainsHoldGet Alert
05/14/2024Buy Now87.76%B of A Securities
Allen Lutz62%
$16.5 → $13.5MaintainsNeutralGet Alert
04/29/2024Buy Now108.62%Wells Fargo
Stephen Baxter58%
$17 → $15MaintainsEqual-WeightGet Alert
04/26/2024Buy Now192.07%Oppenheimer
Michael Wiederhorn63%
$26 → $21MaintainsOutperformGet Alert
04/26/2024Buy Now108.62%TD Cowen
Charles Rhyee37%
$16 → $15MaintainsHoldGet Alert
04/26/2024Buy Now94.71%Evercore ISI Group$15 → $14MaintainsIn-LineGet Alert
04/26/2024Buy Now150.35%RBC Capital
Sean Dodge48%
$25 → $18MaintainsOutperformGet Alert
04/26/2024Buy Now122.53%Stifel
David Grossman62%
$21 → $16MaintainsHoldGet Alert
04/26/2024Buy Now178.16%Barclays
Steve Valiquette55%
$25 → $20MaintainsOverweightGet Alert
04/26/2024Buy Now247.71%Canaccord Genuity
Richard Close46%
$28 → $25MaintainsBuyGet Alert
04/26/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
04/05/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
03/06/2024Buy Now136.44%Truist Securities
Jailendra Singh38%
$23 → $17MaintainsHoldGet Alert
02/29/2024Buy Now205.98%Cantor Fitzgerald
Sarah James53%
→ $22Initiates → OverweightGet Alert
02/26/2024Buy Now136.44%Leerink Partners
Michael Cherny79%
→ $17Initiates → Market PerformGet Alert
02/21/2024Buy Now150.35%DA Davidson
Gil Luria49%
$22 → $18MaintainsNeutralGet Alert
02/21/2024Buy Now164.26%Citigroup
Daniel Grosslight44%
$21 → $19MaintainsNeutralGet Alert
02/21/2024Buy Now247.71%RBC Capital
Sean Dodge48%
$30 → $25MaintainsOutperformGet Alert
02/21/2024Buy Now247.71%Barclays
Steve Valiquette55%
$26 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now247.71%Piper Sandler
Jessica Tassan41%
$30 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now289.43%Canaccord Genuity
Richard Close46%
$34 → $28MaintainsBuyGet Alert
11/17/2023Buy Now164.26%JP Morgan
Lisa Gill60%
$33 → $19MaintainsNeutralGet Alert
10/25/2023Buy Now317.25%RBC Capital
Sean Dodge48%
$35 → $30MaintainsOutperformGet Alert
10/25/2023Buy Now261.61%Oppenheimer
Michael Wiederhorn63%
$35 → $26MaintainsOutperformGet Alert
10/23/2023Buy Now192.07%Citigroup
Daniel Grosslight44%
$29 → $21MaintainsNeutralGet Alert
10/20/2023Buy Now192.07%Citigroup
Daniel Grosslight44%
$29 → $21MaintainsNeutralGet Alert
09/25/2023Buy Now289.43%Truist Securities
Jailendra Singh38%
→ $28ReiteratesHold → HoldGet Alert
07/26/2023Buy Now289.43%Stephens & Co.
Jeff Garro38%
→ $28ReiteratesEqual-Weight → Equal-WeightGet Alert
07/26/2023Buy Now386.79%RBC Capital
Sean Dodge48%
→ $35ReiteratesOutperform → OutperformGet Alert
07/26/2023Buy Now303.34%Citigroup
Daniel Grosslight44%
$31 → $29MaintainsNeutralGet Alert
07/26/2023Buy Now275.52%Credit Suisse
Jonathan Yong66%
→ $27ReiteratesNeutral → NeutralGet Alert
04/28/2023Buy Now303.34%Deutsche Bank
George Hill64%
$27 → $29MaintainsHoldGet Alert
04/27/2023Buy Now331.15%Citigroup
Daniel Grosslight44%
$30 → $31MaintainsNeutralGet Alert
04/27/2023Buy Now386.79%RBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy Now275.52%Credit Suisse
Jonathan Yong66%
→ $27Reiterates → NeutralGet Alert
04/27/2023Buy Now303.34%Barclays
Steve Valiquette55%
$28 → $29MaintainsEqual-WeightGet Alert
04/12/2023Buy Now247.71%Stephens & Co.
Jeff Garro38%
→ $25Initiates → Equal-WeightGet Alert
03/10/2023Buy Now275.52%Credit Suisse
Jonathan Yong66%
$30 → $27MaintainsNeutralGet Alert
03/06/2023Buy Now400.7%Canaccord Genuity
Richard Close46%
$40 → $36MaintainsBuyGet Alert
03/06/2023Buy Now219.89%Wells Fargo
Stan Berenshteyn40%
$28 → $23MaintainsEqual-WeightGet Alert
02/28/2023Buy Now317.25%Citigroup
Daniel Grosslight44%
$33 → $30MaintainsNeutralGet Alert
02/27/2023Buy Now275.52%Deutsche Bank
George Hill64%
$31 → $27MaintainsHoldGet Alert
02/27/2023Buy Now358.97%JP Morgan
Lisa Gill60%
$35 → $33MaintainsNeutralGet Alert
02/23/2023Buy Now386.79%Oppenheimer
Michael Wiederhorn63%
$37 → $35MaintainsOutperformGet Alert
02/23/2023Buy Now386.79%RBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
02/23/2023Buy Now372.88%SVB Leerink
Stephanie Davis41%
→ $34UpgradeMarket Perform → OutperformGet Alert
01/19/2023Buy Now414.6%Oppenheimer
Colin Rusch53%
$45 → $37MaintainsOutperformGet Alert
01/18/2023Buy Now289.43%Barclays
Marc Solecitto60%
$32 → $28MaintainsEqual-WeightGet Alert
12/13/2022Buy Now358.97%Citigroup
Daniel Grosslight44%
$36 → $33MaintainsNeutralGet Alert
10/31/2022Buy Now317.25%Credit Suisse
Jonathan Yong66%
$35 → $30MaintainsNeutralGet Alert
10/27/2022Buy Now400.7%Citigroup
Daniel Grosslight44%
$38 → $36MaintainsNeutralGet Alert
10/27/2022Buy Now345.06%Barclays
Steve Valiquette55%
$33 → $32MaintainsEqual-WeightGet Alert
10/25/2022Buy Now456.33%DA Davidson
Robert Simmons53%
$45 → $40MaintainsBuyGet Alert
10/24/2022Buy NowGuggenheim
Sandy Draper73%
UpgradeSell → NeutralGet Alert
10/21/2022Buy Now303.34%Truist Securities
Jailendra Singh38%
$35 → $29MaintainsHoldGet Alert
10/11/2022Buy Now358.97%Barclays
Steve Valiquette55%
$40 → $33MaintainsEqual-WeightGet Alert
09/28/2022Buy Now386.79%RBC Capital
Sean Dodge48%
$53 → $35MaintainsOutperformGet Alert
09/27/2022Buy Now331.15%Deutsche Bank
George Hill64%
$34 → $31MaintainsHoldGet Alert
09/16/2022Buy NowKeybanc
Scott Schoenhaus41%
Initiates → Sector WeightGet Alert
09/07/2022Buy Now386.79%Truist Securities
Jailendra Singh38%
→ $35Initiates → HoldGet Alert
08/17/2022Buy Now247.71%Guggenheim
Sandy Draper73%
→ $25DowngradeNeutral → SellGet Alert
08/12/2022Buy Now525.87%DA Davidson
Robert Simmons53%
→ $45Initiates → BuyGet Alert
08/02/2022Buy Now386.79%Berenberg
Ravi Misra34%
$42 → $35DowngradeBuy → HoldGet Alert
08/02/2022Buy Now372.88%Cowen & Co.
Charles Rhyee37%
$58 → $34DowngradeOutperform → Market PerformGet Alert
07/28/2022Buy Now400.7%Goldman Sachs
Cindy Motz29%
$55 → $36DowngradeBuy → NeutralGet Alert
07/28/2022Buy Now456.33%Barclays
Steve Valiquette55%
$42 → $40MaintainsEqual-WeightGet Alert
07/28/2022Buy NowNeedham
Ryan MacDonald57%
DowngradeBuy → HoldGet Alert
07/28/2022Buy Now456.33%Piper Sandler
Jessica Tassan41%
$42 → $40MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Teladoc Health (TDOC) stock?

A

The latest price target for Teladoc Health (NYSE:TDOC) was reported by B of A Securities on April 11, 2025. The analyst firm set a price target for $8.00 expecting TDOC to rise to within 12 months (a possible 11.27% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teladoc Health (TDOC)?

A

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by B of A Securities, and Teladoc Health maintained their neutral rating.

Q

When was the last upgrade for Teladoc Health (TDOC)?

A

The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.

Q

When was the last downgrade for Teladoc Health (TDOC)?

A

The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.

Q

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.

Q

Is the Analyst Rating Teladoc Health (TDOC) correct?

A

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $9.50 to $8.00. The current price Teladoc Health (TDOC) is trading at is $7.19, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch